INTC
61
5
GM
57
-6
FRT
45
2
NWL
39
-2
SIG
67
-5
EXR
44
4
PGR
40
3
FOX
26
-2
FE
62
2
PNR
30
-2
PSA
35
15
EMR
51
-2
PNC
59
3
AMGN
39
-5
EL
25
-2
HSIC
51
3
ETN
55
-2
RRC
70
12
TDC
63
3
MUR
49
2
INTC
61
5
GM
57
-6
FRT
45
2
NWL
39
-2
SIG
67
-5
EXR
44
4
PGR
40
3
FOX
26
-2
FE
62
2
PNR
30
-2
PSA
35
15
EMR
51
-2
PNC
59
3
AMGN
39
-5
EL
25
-2
HSIC
51
3
ETN
55
-2
RRC
70
12
TDC
63
3
MUR
49
2
Financhill
Back

Ares Dynamic Credit Allocation Fund Vs. Novo Nordisk A/S Industry Stock Comparison

Sell
26

ARDC
Ares Dynamic Credit Allocation Fund

Last Price:
$11.97
Seasonality Move:
3.04%
Sell
27

NVO
Novo Nordisk A/S

Last Price:
$36.97
Seasonality Move:
12.55%
Sell
26
Ares Dynamic Credit Allocation Fund (ARDC) is a Sell

Is Ares Dynamic Credit Allocation Fund a Buy, Sell or Hold?

  • The current Ares Dynamic Credit Allocation Fund [ARDC] share price is $11.98. The Score for ARDC is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • ARDC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Novo Nordisk A/S (NVO) is a Sell

Is Novo Nordisk A/S a Buy, Sell or Hold?

  • The current Novo Nordisk A/S [NVO] share price is $36.98. The Score for NVO is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ARDC Stock Price Chart

What is Ares Dynamic Credit Allocation Fund's stock price today?

  • The Ares Dynamic Credit Allocation Fund share price today is $11.98
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARDC is experiencing slight buying pressure.

NVO Stock Price Chart

What is Novo Nordisk A/S's stock price today?

  • The Novo Nordisk A/S share price today is $36.98
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.

ARDC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.2 Sell
Relative Strength Index (14 RSI): 36.8 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.02 - 12.44) Sell
Bollinger Bands (100): (12.56 - 13.68) Sell

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.87 Sell
Relative Strength Index (14 RSI): 39.83 Sell
Chaikin Money Flow: 14566902 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.41 - 38.59) Sell
Bollinger Bands (100): (39.84 - 55.48) Sell

ARDC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.06 Sell
20-day SMA: 12.15 Sell
50-day SMA: 12.75 Sell
200-day SMA: 13.67 Sell
8-day EMA: 12.06 Sell
20-day EMA: 12.21 Sell
50-day EMA: 12.6 Sell
200-day EMA: 13.44 Sell

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.4 Buy
20-day SMA: 37.4 Sell
50-day SMA: 44.19 Sell
200-day SMA: 53.09 Sell
8-day EMA: 36.61 Buy
20-day EMA: 37.8 Sell
50-day EMA: 42.18 Sell
200-day EMA: 54.43 Sell

Ares Dynamic Credit Allocation Fund Earnings Growth & ARDC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Novo Nordisk A/S Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.29 per share, and an increase next year of $0.05 per share.

Ares Dynamic Credit Allocation Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk A/S Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):